Crohns disease inflammatory bowel disease Ulcerative Colitis
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients with inflammatory bowel disease and IBS-like symptoms, age >11 years will be recruited. Patients have to be in remission of their inflammatory bowel disease as defined as no signs of inflammatory bowel disease, low inflammatory markers in laboratory tests and no disease activity on imaging studies of the intestine. IBS-like symptoms are defined as abdominal pain for at least two months, fulfilling the pediatric and adult Rome-III criteria for IBS
Exclusion criteria
Exclusion criteria: Exclusion criteria are a concomitant organic gastrointestinal disease, treatment by another health care professional for abdominal symptoms, mental retardation, insufficient knowledge of the Dutch language and previous hypnotherapy treatment.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary outcome will be the number of patients with > 50% reduction in intensity and frequency of abdominal pain. | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary outcomes include the change in pain scores during follow-up, IBD disease activity score, quality of life scores, depression and anxiety scores, use of additional medication, health utility, societal costs, school absence and absence of work, measured after treatment and at 3 and 6 months follow-up. | — |
Countries
Netherlands